Sanger Sequencing Diagnostic Services Market Research Report – Segmentation By Type (Instruments, Reagents, and Software & Services); By End User (Academic and Research Institutes, Hospitals and Clinics, and Pharmaceutical and Biotechnology Companies); By Technology (Sanger Sequencing, and Next-Generation Sequencing); and Region; - Size, Share, Growth Analysis | Forecast (2024– 2030)
The Sanger Sequencing Diagnostic Services Market was valued at USD 1.92 billion in 2023 and is projected to reach a market size of USD 6.3 billion by the end of 2030. Over the forecast period of 2024-2030, the market is estimated to grow at a CAGR of 18.5%.
In recent past years, Sanger sequencing is renowned for its accuracy and reliability in diagnosing high-quality DNA sequencing data. However, Sanger sequencing is typically restricted in terms of the number of samples that can be prepared simultaneously. Additionally, Sanger sequencing, with its ability to accurately sequence specific genes or regions of interest, plays a pivotal role in diagnostic testing, identifying disease-causing mutations and monitoring treatment response. The growing adoption of clinical genomics provides opportunities for the Sanger sequencing market. Although, obtaining regulatory approvals and reimbursement coverage for Sanger sequencing-based tests can be challenging, needing time and resources to navigate the regulatory environment which acts as a bottle neck for the growth of the market. “Diagnostics” dominates the application segment of the Sanger Sequencing market owing to the rising demand for better methods of diagnosis and testing in patients.
Key Market Insights:
China is projected to witness major growth in the near future, due to increase in R&D investment and surge in applications of Sanger’s sequencing. Additionally, the Chinese region offers noteworthy opportunities for the venture capitalists and investors, as the developed markets are comparatively saturated.
The introduction of large-scale research utilizing NGS methods results in the creation of new core information concerning cancer precision medicine. The healthcare business strives to enhance technology in order to reduce health issues and extend human longevity. Resultantly, worldwide companies, as well as hundreds of biotechnology start-ups throughout the world, are trying to help mankind by inventing innovative healthcare solutions.
Many of the emerging biotechnology and genetics start-ups are employing DNA sequencing technologies for a range of purposes. These new growing firms offer sequencing services for human and animal genomes. Personal Genomic Diagnostics Inc., based in Baltimore, Maryland, expertise in genome analysis of human cancers. Using sequencing methods and technology, the business makes a patient-specific cancer analysis.
Technological developments in the industry is pushing the market forward.
The market for Sanger's sequencing services is expanding due to technological developments in sequencing methods and its diagnostic services, benefits of Sanger's sequencing, and an increase in genome mapping initiatives. In addition, sequencing applications and deployment in R&D expenditure have added to the market's expansion.
Active Research and development (R&D) activities are fueling growth in the market.
The increased focus that vendors are paying towards developing countries like China, India, and Southeast Asia is anticipated to promote market expansion. The market is expected to observe significant growth in the near future as a result of rising R&D expensing and a boom in Sanger sequencing applications.
Rise in genetic illness is greatly impacting and increasing the need for these services globally.
The wide utilisation of genetic testing on vertebrates and plants, other factors influencing the market's growth include the rising prevalence and familiarity of genetic illnesses and tailored medicine.
Sanger Sequencing Diagnostic Services Market Restraints and Challenges:
NGS technologies have revolutionized genetic sequencing by detecting high-throughput sequencing of entire genomes or exomes at a lower cost per base. Resultantly, the Sanger sequencing market faces competition from NGS platforms, which offer wider applications and higher throughput capabilities. New sequencing technologies are becoming obtainable, such as single-molecule sequencing, which offer faster and more affordable services than traditional Sanger sequencing Diagnostic Services. This has resulted in increased competition and has put downward pressure on the Sanger Sequencing Diagnostic Service market.
Sanger sequencing is congenial for targeted sequencing of specific genes or regions of interest. However, it may not be as suitable for whole-genome or exome sequencing due to its restricted throughput and higher cost per base. This can restrict its utilisation in certain research or clinical settings.
The field of Genomics is continuously evolving, with ongoing research and development efforts in areas like cancer genomics, rare genetic disorders, and infectious diseases. Sanger sequencing is a valuable and significant tool for researchers to validate and confirm genetic variants discovered through next-generation sequencing technologies. The demand for Sanger sequencing in research and development activities presents opportunities for market development.
The Global Sanger Sequencing Service Market is directed by the increasing demand for high-throughput sequencing solutions in the Life Science and Healthcare industries. These solutions are being applied in research activities, drug development, and clinical diagnosis. With advancements in genomic research and personalized medicine, there is a growing necessity for accurate and reliable genetic sequencing technologies like Sanger sequencing and Diagnostic Services. This market opportunity arises from the growing demand for genomic testing to guide customized treatment plans for various diseases. The growing demand for personalized medicine, along with the rising need for accurate and rapid diagnosis of genetic diseases are expected to add to the growth of the market. The growing need for faster DNA sequencing methodologies, the development of new technologies such as next-generation sequencing (NGS) and the increasing deployment in Research & Development activities are some of the other factors driving the Global Sanger Sequencing Diagnostics Service Market.
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
Regional Scope
North America, Europe, APAC, Latin America, Middle East & Africa
Key Companies Profiled
Elantas GmbH (Germany), Axalta Coating Systems (the U.S.), Von Roll Holdings AG (Switzerland), Hitachi Chemicals Company Ltd. (Japan), 3M Company (the U.S.), and Kyocera Corporation (Japan)
Sanger Sequencing Diagnostic Services Market Segmentation By Type:
Instruments
Reagents
Software & Services
Instruments are the hardware components used in Sanger sequencing for performing chemical reactions and physically creating the DNA strands. They aid in automated sequencing processes, such as capillary electrophoresis, thermocyclers, and sequencing workstations. These instruments are designed to be user friendly and can be applied even with minimal training.
Reagents are chemicals utilised in the Sanger sequencing process. These reagents act as catalysts that enable DNA synthesis, replication, and analysis. Some major reagents used in Sanger sequencing services include Taq polymerase, trace buffers, enzymes, fluorescent markers, and primers.
Software and services are used to assist with the analysis and interpretation of large data sets created from Sanger sequencing experiments. Scenarios of software used for Sanger sequencing services include Bio-Rad software packages, Illumina software packages, and Qiagen software. Services used for this purpose involve data management, quality assessment, and interpretation.
Sanger Sequencing Diagnostic Services Market Segmentation By End User:
Academic and Research Institutes
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Academic & Research Institutes are major customers of Sanger Sequencing services, as they need comprehensive and detailed analysis for their research and studies. These services come in several forms, including gene sequencing, DNA sequencing, and other genomics services. Furthermore, due to the large number of academic and research projects, these institutes require more accurate, budget-friendly and high-throughput sequencing technology and services.
Hospitals & Clinics need efficient and reliable technology for genetic testing, diagnosis and counselling for the purpose of early detection and preventive care. Sanger Sequencing Service helps them to accurately diagnose the genetic cause of a disorder or diagnosis using a cost-effective method and thereby strategically manage clinical resources and improve patient care.
Pharmaceutical & Biotechnology Companies apply Sanger Sequencing services to create personalized treatments and therapies to cure complex diseases. These services enable them to better understand the drug interaction with the genome, as well as analyse drug efficacy upon different patients to aid them focus their resources on successful therapeutic products.
Sanger Sequencing Diagnostic Services Market Segmentation By Technology
Sanger Sequencing
Next-Generation Sequencing
Sanger sequencing is a traditional form of DNA sequencing that enables researchers to diagnose the order of nucleotides or bases in a single-stranded DNA molecule. It does this by making a series of fragment lengths, then uses chain-termination techniques and a DNA-dependent DNA polymerase to add labelled nucleotides to the end of these fragments. The chain stops when a labelled or unlabelled nucleotide is incorporated, and the fragments are then differentiated into individual pieces according to size, after which they are identified according to their respective labels.
Next-Generation Sequencing (NGS) is a powerful and latest technology used in the sequencing of millions of DNA strands simultaneously. It is a more advanced form of DNA sequencing that is more budget-friendly, faster, and more accurate than traditional methods. This technology is utilised to identify disease-causing genes, sequence several genomes in parallel and determine the function of multiple genes at once. NGS works by using massively parallel sequencing of DNA fragments, which is accomplished through high-throughput DNA sequencing, software, and robotics that analyse and decode the generated data.
Sanger Sequencing Diagnostic Services Market Segmentation By Region:
North America
Asia-Pacific
Europe
South America
Middle East and Africa
North America is predicted to dominate the Sanger sequencing market owing to the rising number of geriatric population and advancing medical technology adoption. This is driven by the increasing need for personalized medicine, as well as the excess use of genomic sequencing in research and clinical applications. Furthermore, the availability of advanced sequencing technologies and the growing number of partnerships between academic and industry partners are also contributing to the development of the market.
Asia-Pacific is expected to experience significant growth during the forecast period of 2023 to 2030 due to an expansion in research and development expenditure and an increase in the utilization of Sanger sequencing. Also, the region's large population and the obtainability of advanced sequencing technologies are also contributing to the growth of the market. The market is further driven by the rising number of collaborations between public and private organizations.
COVID-19 Impact Analysis on the Sanger Sequencing Diagnostic Services Market:
Outbreakof COVID-19 posed crucial challenges in all the sectors including Sanger Sequencing Diagnostic sector across the globe. It has resulted in the negative growth of the Sanger Sequencing services as supply chain disruptions due to trade regulations and restrictions affected the product demand.
Latest Trends:
Personalized medicine is an emerging trend in the Healthcare industry which eyes on providing customized treatments to individuals based on their personal genetic make-up. As the technology for Sanger sequencing is becoming more modernized, there is an increasing demand for personalized medicine, as Sanger sequencing enables more detailed data for the development of treatments for different types of diseases.
Sanger sequencing is increasingly being used in drug discovery and development, as it provides a comprehensive and extensive look at the genetic sequence of a particular organism. This permits researchers to gain greater insight into the genetic make-up of a particular organism, which can lead to the birth of new drugs and treatments. Sanger sequencing is also being used to figure out new gene targets, which can lead to the development of more targeted treatments.
Key Players:
Thermo Fisher Scientific Inc (U.S.)
Source BioScience (U.K.)
GenScript (U.S.)
LGC Limited (U.K.)
CeMIA (U.S.),
Quintara Biosciences (U.S.)
GenHunter Corporation (U.S.)
GENEWIZ (U.S.), Nucleics (U.K.)
SciGenom Labs Pvt. Ltd (India)
To Learn more about this report,
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Key Market Insights:
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
Global Automotive Lighting Market Drivers:
Using cutting-edge technology to illuminate the road, safety serves as a guiding light.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Beyond Performance-Based Luxuries Redefined by Light.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
Fuel Efficiency Takes the Lead: Illuminating Sustainability
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
To Learn more about this report,
Global Automotive Lighting Market Restraints and Challenges:
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
Global Automotive Lighting Market Opportunities:
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
AUTOMOTIVE LIGHTING MARKET REPORT COVERAGE:
To Learn more about this report,
Global Automotive Lighting Market Segmentation: By Application
Exterior Lighting
Interior Lighting
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
Global Automotive Lighting Market Segmentation: By Technology
Halogen
LED (Light-Emitting Diode)
Xenon
Emerging Technologies
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Global Automotive Lighting Market Segmentation: By Vehicle Type
Passenger Cars
Commercial Vehicles
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Global Automotive Lighting Market Segmentation: By Sales Channel
OEM (Original Equipment Manufacturers)
Aftermarket
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
To Learn more about this report,
Global Automotive Lighting Market Segmentation: By Region
North America
Asia-Pacific
Europe
South America
Middle East and Africa
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
COVID-19 Impact Analysis on the Global Automotive Lighting Market:
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
Recent Trends and Developments in the Global Automotive Lighting Market:
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Fill out the form below and our team will get back to you shortly
FAQ's
The Sanger Sequencing Diagnostic Services Market was valued at USD 1.92 billion in 2023 and is projected to reach a market size of USD 6.3 billion by the end of 2030. Over the forecast period of 2024-2030, the market is estimated to grow at a CAGR of 18.5%.
The market for Sanger's sequencing services is expanding due to technological developments in sequencing methods and its diagnostic services.
Sanger Sequencing Diagnostic Services Market is segmented based on type, technology, end user, and Region.
North America is the most dominant region for the Sanger Sequencing Diagnostic Services Market.
. Thermo Fisher Scientific Inc, Source BioScience, and GenScript are the few of the key players operating in the Sanger Sequencing Diagnostic Services Market.
More related reports
Get expert-driven market research reports from a leading research partner to help you navigate the future of the global industry.
Report Code: VMR-19361 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Newborn Screening Market was valued at approximately USD 6.14 Billion. It is projected to grow at a CAGR of around 7.6% during the forecast period of 2026–2030, reaching an estimated USD 8.86 Billion by 2030...
Report Code: VMR-19360 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Home Diagnostics & Self-Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41...
Report Code: VMR-19359 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Home Diagnostics & Self-Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41...
Report Code: VMR-19358 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Clinical Microbiology Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41 Bi...
Report Code: VMR-19356 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Global Fertility Services & IVF Technology Market was valued at approximately USD 53 Billion and is projected to reach around USD 82.30 Billion by 2030, expanding at a CAGR of about 9.2% during 2026–2030.
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”